Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

SU-F-T-687: Comparison of SPECT/CT-Based Methodologies for Estimating Lung Dose from Y-90 Radioembolization

Journal Article · · Medical Physics
DOI:https://doi.org/10.1118/1.4956873· OSTI ID:22649242
;  [1];  [2]
  1. Cleveland Clinic, Cleveland, OH (United States)
  2. Cleveland State University, Cleveland, OH (United States)
Purpose: To compare mean lung dose (MLD) estimates from 99mTc macroaggregated albumin (MAA) SPECT/CT using two published methodologies for patients treated with {sup 90}Y radioembolization for liver cancer. Methods: MLD was estimated retrospectively using two methodologies for 40 patients from SPECT/CT images of 99mTc-MAA administered prior to radioembolization. In these two methods, lung shunt fractions (LSFs) were calculated as the ratio of scanned lung activity to the activity in the entire scan volume or to the sum of activity in the lung and liver respectively. Misregistration of liver activity into the lungs during SPECT acquisition was overcome by excluding lung counts within either 2 or 1.5 cm of the diaphragm apex respectively. Patient lung density was assumed to be 0.3 g/cm{sup 3} or derived from CT densitovolumetry respectively. Results from both approaches were compared to MLD determined by planar scintigraphy (PS). The effect of patient size on the difference between MLD from PS and SPECT/CT was also investigated. Results: Lung density from CT densitovolumetry is not different from the reference density (p = 0.68). The second method resulted in lung dose of an average 1.5 times larger lung dose compared to the first method; however the difference between the means of the two estimates was not significant (p = 0.07). Lung dose from both methods were statistically different from those estimated from 2D PS (p < 0.001). There was no correlation between patient size and the difference between MLD from PS and both SPECT/CT methods (r < 0.22, p > 0.17). Conclusion: There is no statistically significant difference between MLD estimated from the two techniques. Both methods are statistically different from conventional PS, with PS overestimating dose by a factor of three or larger. The difference between lung doses estimated from 2D planar or 3D SPECT/CT is not dependent on patient size.
OSTI ID:
22649242
Journal Information:
Medical Physics, Journal Name: Medical Physics Journal Issue: 6 Vol. 43; ISSN 0094-2405; ISSN MPHYA6
Country of Publication:
United States
Language:
English

Similar Records

Lung Dose Calculation With SPECT/CT for {sup 90}Yittrium Radioembolization of Liver Cancer
Journal Article · Thu Feb 28 23:00:00 EST 2013 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22224389

Pre- and post-treatment image-based dosimetry in 90Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit
Journal Article · Tue Dec 28 19:00:00 EST 2021 · Physics in Medicine and Biology · OSTI ID:1865365

The Caudate Lobe: The Blind Spot in Radioembolization or an Overlooked Opportunity?
Journal Article · Wed Jun 15 00:00:00 EDT 2016 · Cardiovascular and Interventional Radiology · OSTI ID:22642497